FDA Issues Safety Letter about Thermo Fisher Scientific TaqPath COVID-19 Combo Kit

  • Home
  • FDA Issues Safety Letter about Thermo Fisher Scientific TaqPath COVID-19 Combo Kit

COLA is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. Below is a link to the most recent message on the FDA-issued safety letter about Thermo Fisher Scientific’s TaqPath COVID-19 Combo Kit.

 

FDA Issues Safety Letter about Thermo Fisher Scientific TaqPath COVID-19 Combo Kit

On August 17, 2020, the U.S. Food and Drug Administration (FDA) issued a safety letterexternal icon about the Thermo Fisher Scientific TaqPath COVID-19 Combo Kit. 

Read more here.

Advertisement

Posts by Tag

Search Blog: